2025-06-11-花旗集团-安道拓（ADNT）_安道拓（ADNT.N）_管理层会议反馈_10页_221kb

Adient (ADNT.N) - Citi Research Summary

Key Insights and Outlook

• Higher US tariffs have minimal impact on Adient so far, creating a market share opportunity due to GM and other manufacturers' US production shifts.
• Vehicle production and low US dealer inventory levels support upward revisions in market expectations.
• ADNT guidance indicates first-half results beat expectations and tariff exposure is manageable, with 75% mitigation.

Financial Performance

• Q3 2024 adjusted EBITDA projected at $209 million (5.8% of revenue), compared to $202 million (5.4%) in 2024.
• Full-year 2025 EBITDA estimate: $850 million, with upside potential if current and tariff trends persist.
• Results primarily unaffected by tariffs in the first half, but risks in the second half from tariff effects may be offset by European restructuring savings.

Capital and Strategy

• EBITDA margin improved from 4.8% in 2022 to 6.0% in 2024, with debt reduced nearly 50% since June 2021.
• Share repurchase program achieved 12% reduction in shares since 2023, with accelerated pace expected.
• Cost actions and program portfolio enhancements drive margin improvement in a recovering industry.

Valuation

• Current market cap: $1,480M.
• Target price: $18, representing a 4.0x EBITDA multiple and 6.0x P/E, applied to 2025-2026E assumptions.
• Expected share price return: 2.2%, total return: 2.2%, reflecting better-than-expected performance but discounted for tariff uncertainties.
• Prior price: $17.62.

Risks

• Auto industry risks include capital intensity, cyclical demand, economic downturns, pricing volatility, and bankruptcy potential.
• Outcomes could lead to stock outperformance or underperformance relative to target.

Recommendation

• Buy, with a target price of $18 due to positive outlook and potential share gains.